A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00694785
Recruitment Status : Withdrawn (Sponsor decided not to go forward with the study.)
First Posted : June 10, 2008
Last Update Posted : August 21, 2009
Information provided by:
Archemix Corp.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2009
  Study Completion Date : No date given